Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 1 |
---|
Ligand | BDBM495191 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ERK2 Enzymatic Assay |
---|
IC50 | <150±n/a nM |
---|
Citation | Guichou, J; Bories, C; Geoffroy, C; Duquenne, C; Gelin, M; Labesse, G; Bessin, Y; Mathieu, L Zaindole derivatives and their use as ERK kinase inhibitors US Patent US10995089 Publication Date 5/4/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 1 |
---|
Name: | Mitogen-activated protein kinase 1 |
Synonyms: | ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK |
Type: | Ser/Thr Protein Kinase |
Mol. Mass.: | 41392.76 |
Organism: | Homo sapiens (Human) |
Description: | P28482 |
Residue: | 360 |
Sequence: | MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE
HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH
LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH
TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI
LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK
RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
|
|
|
BDBM495191 |
---|
n/a |
---|
Name | BDBM495191 |
Synonyms: | 1-(5-Chloro-2-(2-methoxyethoxy)benzyl)-4-(5-morpholino-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2(1H)-one | US10995089, Example 37 | US11708364, Example 37 |
Type | Small organic molecule |
Emp. Form. | C26H27ClN4O4 |
Mol. Mass. | 494.97 |
SMILES | COCCOc1ccc(Cl)cc1Cn1ccc(cc1=O)-c1c[nH]c2ncc(cc12)N1CCOCC1 |
Structure |
|